Credit: Shutterstock. Adlarity is a once-weekly transdermal formulation of donepezil that is designed to be worn for 7 days with consistent adhesion. The Food and Drug Administration (FDA) has ...
March 30, 2011 (Toronto, Ontario) — Caregivers using a transdermal patch to administer cholinesterase inhibitor (ChEI)–based therapy in individuals with Alzheimer's disease (AD) report greater overall ...
The U.S. Food and Drug Administration announced last week that a pharmaceutical company is removing a fentanyl patch from patient and pharmacy access because of a packaging flaw that has resulted in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback